Curtis McMurtrey

Title: **Curtis McMurtrey: Innovator in Molecular Medicine**

Introduction

Curtis McMurtrey, based in Oklahoma City, OK, is a distinguished inventor known for his significant contributions to the field of molecular medicine. With a total of two patents to his name, McMurtrey's work focuses on advancing our understanding and treatment of diseases through innovative solutions.

Latest Patents

McMurtrey’s latest patents include:

1. **Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof** - This patent discloses compositions that include an isolated, class I HLA-E trimolecular complex featuring a peptide ligand unique to infected cells. It also details isolated compositions comprising the three components of the trimolecular complex and/or a polynucleotide encoding one or more of these components.

2. **Small molecules that bind MR1** - This patent presents small molecules and pharmaceutical compositions that can be utilized in the treatment of diseases associated with the major histocompatibility complex (MHC) molecule MR1.

Career Highlights

Throughout his career, McMurtrey has worked with renowned institutions such as the University of Oklahoma and Oregon Health & Science University. His research has been pivotal in creating innovative therapeutic approaches for complex medical challenges.

Collaborations

Curtis McMurtrey has collaborated with notable peers, including William H. Hildebrand and David Lewinsohn. These collaborations have significantly contributed to his research output and patent developments.

Conclusion

Overall, Curtis McMurtrey stands out as a leading inventor in the realm of molecular medicine. His patents reflect a deep commitment to understanding and addressing critical health issues, demonstrating the impact of innovation in the medical field.